A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia

Milena Kohn, Marc Delord, Maureen Chbat, Amina Guemriche, Fatiha Merabet, Anne-Laure Roupie, Naelle Lombion, Hassan Farhat, Thomas Longval, Aurélie Cabannes-Hamy

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)1454
Number of pages1
JournalHaematologica
Volume107
Issue number6
Publication statusPublished - 2022

Cite this